Inactivation of the von Hippel–Lindau (VHL) tumour-suppressor gene is linked to the development of several different tumour types in humans, including tumours of the kidney, retina, central ...
Welireg (belzutifan), an oral HIF-2 alpha inhibitor, has been approved by the FDA for adults with von Hippel-Lindau (VHL) disease, an inherited condition caused by a mutation in the VHL gene that ...
In final draft guidance due to be finalised before the end of the month, Welireg (belzutifan) has been recommended as an option for treating adults with von Hippel-Lindau (VHL) disease ...
Based in Brazil, VHL Sistemas has established itself as a trusted name in the notary space, delivering cutting-edge technology to optimize productivity, enhance usability, and ensure information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback